Generalized lipodystrophy, congenital and acquired (lipoatrophy)

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 85, Issue 413, 1996, Pages 2-28

  Seip, M ^a   Trygstad, O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acanthosis nigricans; anabolic syndrome; generalized lipodystrophy; hypermetabolism; hypertrophic cardiomyopathy; lipoatrophic diabetes

Indexed keywords

ADIPOSE TISSUE; ADOLESCENT; CHILD; CLINICAL ARTICLE; ENERGY RESOURCE; FEMALE; HUMAN; INFANT; INSULIN RESISTANCE; LIPID METABOLISM; LIPOATROPHY; LIPODYSTROPHY; MALE; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW;

EID: 0029895842     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (129)

1. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab 1954;14:193-204
2. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome? Acta Paediatr Scand 1959;48:555-74
3. Seip M, Trygstad O. Generalized lipodystrophy. Arch Dis Child 1963;38:447-53
4. Seip M. Generalized lipodystrophy. Ergeb Inn Med Kinderheilkund 1971;31:59-95
5. Ziegler LH. Lipodystrophics: report of seven cases. Brain 1928;51:147-61
6. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbances. Lancet 1946;i:724-31, 773-5
7. Gonzales JRG, Martin EA, Hidalgo BA, Leuten AN, Diaz OD, de Acosta Fernandez OM. Lipodistrofia generalizada congénita. Reporte de 6 casos. Rev Cubana Med 170;9:187-203
8. Enzi G, Digito M, Baldo-Enzi G, Cominacini L, Dodi G, Carraro R, et al. Lipid metabolism in lipoatrophic diabetes. Horm Metab Res 1988;20:587-91
9. Robert JJ, Rakotoambinina B, Cochet I, Fousslier V, Magre J, Darmaun D, et al. The development of hyperglycaemia in patients with insulinresistant generalized lipoatrophic syndromes. Diabetologia 1993;36:1288-92
10. Boucher BJ, Cohen RD, Frankel RJ, Mason AS, Broadley G. Partial and total lipodystrophy: Changes in circulating sugar, free fatty acids, insulin and growth hormone following the adminiastration of glucose and of insulin. Clin Endocrinol 1973;2:111-26
11. Najjar SS, Salem GM, Idriss ZH. Congenital generalized lipodystrophy. Acta Paediatr Scand 1975;64:273-9
12. Huseman C, Johanson A, Varma M, Blizzard RM. Congenital lipodystrophy: an endocrine study in three siblines. I: J Pediatr 1978;93:221-6
13. Huseman C, Johanson A, Varma M, Blizzard RM. Congenital lipodystrophy: an endocrine study in three siblings. II: J Pediatr 1979;95:72-4
14. Garg I, Fleckenstein JL, Peshok RM, Grundy SM. Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J Clin Endocrinol Metab 1992;75:358-61
15. Harendra da Silva DG. Congenital lipodystrophy (Seip syndrome) in Sri Lanka. Ceylon Med J 1984;29:205-7
16. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976;294:739-45
17. Pulini M, Raff SB, Chase R, Gordon EE. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors. Ann Intern Med 1976;85:749-51
18. Wajchenberg BL, Filbo JM, Ventrella C, Giannini SD, Liberman B, Hoxter G. Lipoatrophic diabetes. A new variant characterizied by tapeto-retinal degeneration, late onset generalized lipoatrophy, insulin-resistant hyperglycemia and hyperlipidemia. Isr J Med Sci 1972;8:793-806
19. Rabson SM, Mendenhall EN. Familial hypertrophy of the pineal body, hyperplasia of adrenal cortex and diabetes mellitus. Report of 3 cases. Am J Clin Pathol 1956;26:283-90
20. Flier JS, Young JB, Landsberg L. Familial insulin resistance with acanthosis nigricans, acral hypertrophy, and muscle cramps. N Engl J Med 1980;303:970-3
21. West RJ, Lloyd JK, Turner WML. Familial insulin-resistant diabetes, multiple somatic anomalies, and pineal hyperplasia. Arch Dis Child 1975;50:703-8
22. Moller DE, Flier JS. Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med 1991;325:938-48
23. Montenovesi P, Alttichieri M, Silvestri R. La lipodistrofia generalisada congenita nei quadro della sindrome diencefalica connatale. Minerva Pediatr 1971;23:1259-69
24. Boucher BJ, Cohen RD, France MW, Mason AS. Plasma fatty acid turnover in total lipodystrophy. Clin Endocrinol 1975;4:83-8
25. Gordon H, Pimstone BL, Leary PM, Gordon W. Congenital generalized lipodystrophy with abnormal growth hormone homeostasis. Arch Dermatol 1971;104:551-9
26. Floret D, Longin B, Plauchu H, Gaillard L, Hermier M, Francois R. Diabéte lipoatrophique. Pediatrie 1975;30:837-49
27. Berge T, Brun A, Hansing B, Kjellman B. Congenital generalized lipodystrophy. Acta Pathol Microbiol Scand (A) 1976;84:47-54
28. Kodama S, Kasuga M, Seki A, Ninomiya M, Sakurai T, Morishita Y, et al. Congenital generalized lipodystrophy with insulin-resistant diabetes. Eur J Pediatr 1978;127:111-9
29. Sato T, Saito T, Yasuda K, Yoshinaga K. Effects of insulin and oral antidiabetic agents on the plasma triglyceride levels in lipoatrophic diabetes. Tohoku J Exp Med 1978;124:381-5
30. Pandit A, Bhave S, Sanghvi A. Congenital generalized lipodystrophy (a case report). Indian Pediatr 1979;16:459-61
31. Dorasamy DS. Congenital lipodystrophy: a case report. S Afr Med J 1980;58:417-20
32. Keenan BS, Kirkland RT, Garber AJ, Rubenstein AH, Holcombe JH, Potts VE, et al. The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes. Metabolism 1980;29:1214-24
33. Barela TD, Wogenrich J, Greenberg RE. Insulin resistance and hormonal responses to glucose in a 6-month-old with generalized lipodystrophy. Clin Res 1981;31:123 A
34. Howard BV, Mott DM, Hidaka H, Fields RM, Katzeff H, Howard WJ, et al. Cell culture studies of a patient with congenital lipoatrophic diabetes. Normal insulin binding with alterations in intracellular glucose metabolism and insulin action. Metabolism 1981;30:845-52
35. Wachlicht-Rodbard H, Muggeo M, Kahn CR, Saviolakis CA, Harrison LC, Flier JS. Heterogeneity of the insulin-receptor interaction in lipoatropic diabetes. J Clin Endocrinol Metab 1981;52:416-25
36. Lestradet C, Massol J, Plouvier E, Narboni G, Raffi A. Lipodystrophic généralisée congénitale. Perturbation lipidique. Essais therapeutiques. Arch Fr Pediatr 1985;42:705-7
37. Arico M, Ricordi A, Caselli D, Aschei M, Colombo A, Fratino P. Insulin receptor evaluation in congenital generalized lipodystrophy. Case report of an infant. Helv Paediatr Acta 1987;42:167-71
38. Beylot M, Sautot G, Laville M, Cohen R. Metabolic studies in lipoatrophic diabetes: mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism. Diabete Metab 1988;14:20-4
39. Magré J, Reynet C, Capeau J, Blivet M-J, Picard J. In vitro studies of insulin resistance in patients with lipoatrophic diabetes: evidence for heterogeneous postbinding defects. Diabetes 1988;37:421-8
40. Tsukahara H, Kikuchi K, Kuzuya H, Ito E, Oda Y, Kosaki A, et al. Insulin resistance in a boy with congenital generalized lipodystrophy. Pediatr Res 1988;24:668-72
41. Fleckenstein JL, Garg A, Bonte FJ, Vuitch MF, Peshock RM. The skeleton in congenital, generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imasing and technetium-99m bone scintigraphy. Skeletal Radiol 1992;21:301-6
42. Ghanem Q. Percussion myoedema in a Pakistani boy with Berardinelli-Seip syndrome. J Clin Genet 1990;44:277-8
43. de Craemer D, van Maldergem L, Roels F. Hepatic ultrastructure in congenital total lipodystrophy with special reference to peroxisomes. Ultrastruct Pathol 1992;10:307-16
44. Kuzuya H, Matsuura N, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, et al. Trial of insulinlike growth factor 1 therapy for patients with extreme insulin resistance syndromes. Diabetes 1993;42:696-705
45. van der Vorm ER, Kuipers A, Bodencamp JW, Kleijer WJ, van Maldergem L, Herwig J, et al. Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors. Diabctologia 1993;36:172-4
46. Naito C, Togawa K. A possible role of circulating lipoprotein-triglycerides in the increase in concentration of free fatty acids and in insulin resistance in "total" lipodystrophy. J Clin Endocrinol Metab 1974;39:1030-7
47. Griffits HJ, Rossini AA. A case of lipoatrophic diabetes. Radiology 1975;114:329-30
48. Rossini AA, Self J, Aoki T, Goldman RF, Newmark RS, Meguid MM, et al. Metabolic and endocrine studies in a case of lipoatrophic diabetes. Metabolism 1977;26:637-50
49. Lieberman-Leigh S, Davis JA. Generalized lipodystrophy. J R Soc Med 1984;77:246-8
50. Guihard J, Tessier R, Laniece M, Faucault J-P, Sibireff J-J, l'Hirondel JL. l'Diabete lipoatrophique (syndrome de Lawrence). Nouvelle observation. Ann Pediatr 1971;18:633-43
51. Leblanc H, Jadaud JM, Dejax C, Saltiel H, Passa P. Diabéte lipoatrophique avec acanthosis nigricans. Normalisation glycémique prolongé par infusion continué d'insuline. Presse Med 1984;13:987-8
52. Corbin A, Upton CV, Mabry CC, Hollingsworth DR. Diencephalic involvement in generalized lipodystrophy. Rationale and treatment with the neuroleptic agent, pimozide. Acta Endocrinol (Copenh) 1974;77:209-20
53. Kawanishi K, Kawamura K, Nishina Y, Goto A, Okada S, Ishida T, et al. Successful immunosuppressive therapy in insulin-resistant diabetes caused by anti-insulin receptor autoantibodies. J Clin Endocrinol Metab 1977;44:15-21
54. Ipp MM, Howard NJ, Tervo RC, Gelfand EW. Sicca syndrome and total lipodystrophy. A case in a fifteen-year-old female patient. Ann Intern Med 1976;85:443-6
55. Mabry CC, Hollingsworth DR. Failure of hypophysectomy in generalized lipodystrophy. J Pediatr 1972;81:990-2
56. Catalano PM, Capeless EL, Simmons GM, Robbins DC, Horton ES. Successful pregnancy outcome in association with lipoatrophic diabetes mellitus. Obstet Gynecol 1990;76:978-9
57. Yanagawa T, Tokoyama A, Noya K, Kasuga Y, Takei I, Maruyama H, et al. Cytophagic histiocytic panniculitis evolving into total lipodystrophy. South Med J 1990;83:1323-6
58. Sasaki T, Ono H, Nakajima N, Sugimoto J. Lipoatrophic diabetes. J Dermatol 1992;19:246-9
59. Stacpoole PW, Alig J, Kilgore LL, Ayala CM, Herbert PN, Zech LA, et al. Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of omega-3 fatty acid administration in two patients. Metabolism 1988;37:944-51
60. Wilson DE, Chan I-F, Stevenson KB, Horton SC, Schipke C. Eucaloric substuttion of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance. J Clin Endocrinol Metab 1983;57:517-23
61. Tzagournis M, George J, Herrold J. Increased growth hormone in partial and total lipoatrophy. Diabetes 1973;22:388-96
62. Mabry CC, Hollingsworth DR, Upton CV, Corbin A. Pituitary-hypothalamic dysfunction in generalized lipodystrophy. J Pediatr 1973;82:625-33
63. Brun D, Gupta DN, Gagné C, Belanger G, Tremblay RR. Etude sur la thermorégulation dans le diabéte lipoatrophique. Union Med Can 1974;103:434-40
64. Choo KE, Sharifah A, Ariffin WA, Mafauzy M. Generalized lipodystrophy. Singapoore Med J 1990;31:290-2
65. Orlandi B, Baldasarre M, Camponozzi FA, Di Stanislao C, Poccia G, De Donatis I. Congenital generalized lipodystrophy associated with multiple sclerosis. Ital J Neurol Sci 1992;13:101-4
66. Mora PF, Ramirez CC, Lender D, Raskin P. Insulin requirements in lipodystrophic diabetes. Diabetic Med 1993;10:863-5
67. Casali RE, Resnick J, Goetz F, Simmons RL, Najarian JS, Kjellstrand C. Renal transplantation in a patient with lipoatrophic diabetes. A case report. Transplantation 1978;26:174-7
68. Klar A, Livni N, Gross-Lieselstein E, Navon P, Shahin A, Branski D. Ultrastructural abnormalities of the liver in total lipodystrophy. Arch Pathol Lab Med 1987;111:197-9
69. Zöllner N, Dörfler H, Wolfram G. Lipoatrophischer Diabetes. Ein Fallbericht. Münch Med Wochenschr 1975;117:1209-14
70. Dörfler H, Wieczorek A, Wolfram G, Zöllner N. Binding of insulin to fibroblasts in lipoatrophic diabetes. Res Exp Med 1977;170:161-8
71. Golden MP, Charles MA, Arquilla ER, Myers GL, Lippe BM, Duckworth WC, et al. Insulin resistance in total lipodystrophy: Evidence for a pre-receptor defect in insulin action. Metabolism 1985;34:330-5
72. Saito I, Saruta A, Yori S, Sakaguchi H. The renal lesion associated with total lipodystrophy. J Am Geriat Soc 1977;25:175-8
73. Sissons JGP, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, et al. The complement abnormalities of lipodystrophy. N Engl J Med 1976;294:461-5
74. Wall P, Platt FW. Familial generalized lipodystrophy. A case report. Rocky Mt Med J 1978;75:142-4
75. Robbins DC, Danforth Jr E, Horton ES, Burse RL, Goldman RF, Sims EAH. The effect of diet on thermogenesis in acquired lipodystrophy. Metabolism 1979;28:908-16
76. Häger A, Heding LG, Larsson Y, Ludvigsson J, Trygstad O. Pancreatic B-cell function and abnormal urinary peptides in a boy with lipoatrophic diabetes and stenosis of the aqueduct of Sylvius. Acta Paediatr Scand 1980;69:537-45
77. Harbour JR, Rosenthal P, Smuckler EA. Ultrastructural abnormalities of the liver in total lipodystrophy. Hum Pathol 1981;12:856-62
78. Soler NG, Wortsman J, Chopra IJ. Lipoatrophic diabetes: endocrine dysfuncion and the response to control of hypertriglyceridemia. Metabolism 1982;31:19-24
79. Ishii J, Abe M, Kubo M, Sumimoto T, Hamada M, Hiwada K, et al. Total lipodystrophy with heart failure and renal failure: Report of a case. Jpn J Med 1989;28:534-7
80. Böhmer K, Hauner H, Philippen R, Gries FA. Erfolgreiche Insulinterapie bei lipatrophischen Diabetes. Dtsch Med Wochenschr 1991;116:454-9
81. Klein S, Jahoor F, Wolfe RR, Stuart CA. Generalized lipodystrophy: in vivo evidence for hypermetabolism and insulin-resistant lipid, glucose and amino acid kinetics. Metabolism 1992;41:893-6
82. de Wazieris B, Wendling D, Fest T, Morin G, Dupond IL. Bone and visceral manifestations of lipoatrophic diabetes. Apropos of a case. Rev Rhum Mal Osteoartic 1992;59:761-4
83. Rognum TO, Bjerve KS, Seip M, Trygstad O, Oseid S. Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy. Acta Endocrinol (Copenh) 1978;88:182-9
84. Letarte J, Russell Fraser T. In vitro studies of subcutaneous tissue from a case of total lipodystrophy. Horm Metab Res 1969;28:195-6
85. Smevik B, Swensen T, Kolbenstvedt A, Trygstad O. Computed tomography and ultrasonography of the abdomen in congenital generalized lipodystrophy. Radiology 1982;142:687-9
86. Oseid S. Studies in congenital generalized lipodystrophy (Seip-Barardinelli syndrome). I. Development of diabetes. Acta Endocrinol (Copenh) 1973;72:475-94
87. Oseid S, Pruett EDR. Studies in congenital generalized lipodystrophy. IV. Effect of muscular exercise on carbohydrate and fat metabolism including plasma levels of IRI and HGH. Acta Endocrinol (Copenh) 1976;83:839-55
88. Miyahara R, Tsutamura C, Sugihara M. A case of generalized lipodystrophy. Hiroshima J Med Sci 1965;14:31-9
89. Havel RJ, Basso L, Kane JP. Mobilization and storage of fat in congenital and late onset forms of "total" lipodystrophy. J Clin Invest 1969;46:1068
90. de Gennes JL, Saltiel H, Tremolieres J, Apfelbaum M, Laudat P. Révision de l'exploration métabolique et endocrinienne d'un cas de diabéte lipo-atrophique. Presse Med 1967;75:2605-10
91. Robbins DC, Sims LAH. Recurrent ketoacidosis in acquried, total lipodystrophy (lipoatrophic diabetes). Diabetes Care 1984;7:381-5
92. Gould CW, Holman GD. The glucose transporter family: structure, function, and tissue-specific expression. Biochem J 1993;295:329-41
93. Livingstone C, Dominiczak AF, Campbell IW, Gould GW. Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4. Clin Sci 1995;89:109-16
94. Afifi AK, Mire-Salman J, Najjar S. The myopathology of congenital generalized lipodystrophy. Light and electron microscopic observations. Johns Hopkins Med J 1976;139:61-8
95. Seip M, Oseid S. The pathogenesis of diabetes mellitus in generalized lipodystrophy. Mod Probl Paediatr 1975;12:180-8
96. Søvik O, Oseid S. Studies in congenital generalized lipodystrophy. II. The effect of patients' plasma on glycogen synthesis in rat diaphragm and adipose tissue in vitro. Acta Endocrinol (Copenh) 1973;72:495-505.
97. Søvik O, Oseid S, Øyasæter S. Studies in congenital generalized lipodystrophy. V. Circulating insulin and proinsulin. Acta Endocrinol (Copenh) 1973;73:731-9
98. Søvik O, Oseid S. Studies in congenital generalized lipodystrophy. VI. Suppressible and non-suppressible insulin-like activities of plasma. Acta Endocrinol (Copenh) 1975;79:720-8
99. Søvik O, Oseid S. Plasma insulin in congenital generalized lipodystrophy. Diabetes in juveniles. Mod Probl Paediatr 1975;12:189-94
100. Hansen BC. Genetics of insulin action. Baillière's Clin Endocrinol Metabl 1993;7:1033-61
101. Taylor SI. Lilly lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin receptor gene. Diabetes 1992;41:1473-90
102. Donohue W, Uchida IJ. Leprechaunism: a euphemism for a rare familial disorder. Pedatrics 1954;45:505-19
103. Reddy SS-K, Muller-Wieland D, Kriauciunas K, Kahn CR. Molecular defects in the insulin receptor in patients with leprechaunism and in their parents. J Lab Clin Med 1989;114:154-70
104. Jospe N, Zhu J, Liu R, Livingston JN, Furnaletto RW. Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor a-subunit in a patient with leprechaunism: binding, phosporylation, biological activity. J Clin Endocrinol Metab 1994;79:1294-302
105. Kahn CR, White MF. The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 1988;82:1151-6
106. Magré J, Grigorescu F, Reynet C, Caron M, Capony J-P, White MF, et al. Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 1989;69:142-50
107. Kriauciunas KM, Kahn CR, Muller-Wieland D, Reddy SK, Taub R. Altered expression and function of the insulin receptor in a family with lipoatrophic diabetes. J Clin Endodrinol Metab 1988;67:1284-93
108. Oseid S, Beck-Nielsen H, Pedersen O, Søvik O. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 1977;296:245-8
109. Trygstad O, Seip M, Oseid S. Lipodystrophic diabetes treated with fenfluramine. Int J Obes 1977;1:287-92
110. Wilson TA, Melton T, Clarke WL. The effect of flenfluramine and caloric restriction on carbohydrate homeostasis in patients with lipodystrophy. Diabetes Care 1983;6:160-5
111. Bjørnstad PG, Semb BKH, Trygstad O, Seip M. Echocardiographic assessment of cardiac function and morphology in patients with generalized lipodystrophy. Eur J Pediatr 1985;144:155-9
112. Rheuban KS, Blizzard RM, Parker MA, Carter T, Wilson T, Gutgesell HP. Hypertrophic cardiomyopathy in total lipodystrophy. J Pediatr 1986;109:301-2
113. Gutgesell HP, Speer ME, Rosenberg HS. Caracterization of the cardiomyopathy in infants of diabetic mothers. Circulation 1980;61:441-50
114. Witzgall H. Hyperlipämische Lipoatrophie. Arztl Wochenschr 1957;12:1093-1100
115. Reaven GM. Characteristics of metabolic syndrome X. Endocrinol Metab (Suppl B) 1995;2:37-42
116. Kem D, Collin D, Martin C. Immunoreactive glucagon in total lipodystrophy. Clin Res 1970;18:122
117. Senior B, Gellis SS. The syndromes of total lipodystrophy and of partial lipodystrophy. Pediatrics 1964;33:593-612
118. Reed WB, Dexter R, Corley C, Fish C. Congenital lipoatrophic diabetes with acanthosis nigricans. The Seip-Lawrence syndrome. Arch Derm 1965;91:326-34
119. Louis LH, Conn JW, Minick MC. Lipoatrophic diabetes: isolation and characterization of an insulin antagonist from urine. Metabolism 1963;12:867-87
120. Chalmers TM, Pawan GLS, Kekwick A. Fat-mobilizing and ketogenic activity of urine extracts: Relationship to corticotropin and growth hormone. Lancet 1960;ii:6-9
121. Foss I, Trygstad O. Lipoatrophy produced in mice and rabbits by a fraction prepared from the urine from patients with congenital generalized lipodystrophy. Acta Endocrinol (Copenh) 1975;80:398-416
122. Trygstad O, Foss I. Subdivision of a human growth hormone preparation into a somatotrophic and adipokinetic-hyperglycemic agent. Acta Endocrinol (Copenh) 1968;58:295-317
123. Nestler JE. Sex hormone binding glubulin: a marker for hyperinsulinemia and/or insulin resistance? J Clin Endocrinol Metab 1993;76:273-4
124. Oseid S. Studies in congenital generalized lipodystrophy. III. Growth hormone levels. Acta Endocrinol (Copenh) 1973;73: 427-36
125. Vinik AI, Wing RR. The good, the bad, and the ugly in diabetic diets. Endocrinol Metab Clin North Am 1992;21:237-79
126. Mabry CC, Hollingsworth DR. Generalized lipodystrophy (lipoatrophic diabetes): evidence for abnormal pituitary function. Pediatr Res 1971;5:397-8
127. Andersson DEH, Röjdmark S. Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus. Acta Med Scand 1981;210:27-33
128. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984;59:971-5
129. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986;315:610-4